For a report overview of this report please contact sara.peerun@visiongainglobal.com (+44 (0) 20 7336 6100) or refer to our website: https://www.visiongain.com/Report/1817/The-Global-ENT-Devices-Market-Forecast-2017-2027 https://www.visiongain.com/

1. ©notice
This material is copyright by visiongain. It is against the law to reproduce any of this material without the prior
written agreement of visiongain.You cannot photocopy, fax, download to database or duplicate in any other way
any of the material contained in this report. Each purchase and single copy is for personal use only.
The Global ENT Devices Market Forecast
2017-2027
Revenue Prospects by Type (Diagnostic, Surgical, Hearing Devices), by
Product (including Endoscopes, Surgical Instruments, Stents, CO2 Lasers,
Vent Tubes, Hearing Aids, Hearing Implants and more) and Geography

2. www.visiongain.com
Contents
1. Report Overview
1.1 Global ENT Devices Market Overview
1.2 Global ENT Devices Market Segmentation
1.3 Overview of Findings
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report
1.7 Who is This Report for?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About visiongain
2. Introduction to Hearing Loss
2.1 Degree of Hearing Loss at Different Frequencies
2.2 Common Signs of Hearing Loss
2.3 Types of Hearing Loss
2.4 Causes of Hearing Loss
2.5 Common Symptoms of Sinusitis
2.6 Market Definition & Scope
2.7 Dynamics
2.7.1 Drivers
2.7.1.1 Aging Population And Increase In Geriatric Hearing Degeneration
2.7.1.2 Prevalence Of Hearing Loss
2.7.1.3 Prevalence of Sinusitis

3. www.visiongain.com
Contents
2.7.1.4 Raising Awareness to Prevent Hearing Loss
2.7.1.5 Adoption and Penetration Rate Of Hearing Aids
2.7.1.6 Technological Advancements
2.7.2 Challenges
2.7.2.1 Cost and Reimbursement
2.7.3 Opportunities
2.7.3.1 Emerging Markets
2.7.3.2 Cochlear Implants Segment
2.7.3 Hearing Healthcare Trends and Strategies
2.8 Regulation of Medical Devices
2.8.1 The US Approval and Regulation System
2.8.2. The EU Approval and Regulation System
2.8.2.1 Post-Marketing Surveillance in the EU
3. ENT Devices: World Market 2016-2027
3.1 ENT Devices: Global Market Overview, 2016
3.2 ENT Devices Market Forecast 2016-2027
3.3 Market Share of Leading ENT Devices by Type
4. Diagnostic ENT Devices: Market Forecast 2016-2027
4.1 ENT Endoscope Market Forecast 2016-2027
4.1.1 Rigid Endoscope Market Forecast 2016-2027
4.1.2 Flexible Endoscope Market Forecast 2016-2027
4.2 Hearing Screening Devices Market Forecast 2016-2027
5. Surgical ENT Devices Market Forecast 2016-2027
5.1 Powered Surgical Instrument Market Forecast 2016-2027
5.2 Radiofrequency Handpieces Market Forecast 2016-2027
5.3 Handheld Instrument Market Forecast 2016-2027

4. www.visiongain.com
Contents
5.4 Balloon Sinus Dilation Systems Market Forecast 2016-2027
5.5 Nasal Splints & Stents Market Forecast 2016-2027
5.6 Bronchial/Tracheal Stents Market Forecast 2016-2027
5.7 Vent Tubes Market Forecast 2016-2027
5.8 CO2 Lasers Market Forecast 2016-2027
5.9 Image-guided Surgery Systems Market Forecast 2016-2027
6. Hearing Devices Market Forecast 2016-2027
6.1 Hearing Aids Market Forecast 2016-2027
6.1.1 Behind-the-Ear (BTE) Aid Market Forecast 2016-2027
6.1.2 In-The-Ear Aid Market Forecast 2016-2027
6.1.3 Receiver-In-The-Ear (RITE) Market Forecast 2016-2027
6.1.4 Canal hearing Aids Market Forecast 2016-2027
6.2 Hearing Implants Market Forecast 2016-2027
6.2.1 Cochlear Implant Market Forecast 2016-2027
6.2.2 Bone-Anchored Hearing Systems (BAHS) Market Forecast 2016-2027
6.2.3 Auditory Brainstem Implant Market Forecast 2016-2027
6.2.4 Middle Ear Implants Market Forecast 2016-2027
7. Leading National Markets 2016-2027
7.1 Geographical Breakdown of the ENT Devices Market
7.2 World ENT Devices Market: Regional Forecast 2017-2027
7.2.1 How Will Regional Market Shares Change to 2027?
7.3 The US ENT Devices Market 2016-2027
7.3.1 US ENT Devices Market Forecast 2017-2027
7.3.2 US ENT Devices Market: Trends and Developments
7.4 The EU ENT Devices Market 2016-2027
7.4.1 EU5 ENT Devices Market Forecast 2016-2027
7.4.2 Germany ENT Devices Market Forecast 2016-2027

5. www.visiongain.com
Contents
7.4.2.1 German ENT Devices Market: Trends and Developments
7.4.3 French ENT Devices Market Forecast 2016-2027
7.4.4 UK ENT Devices Market Forecast 2016-2027
7.4.5 Spanish ENT Devices Market Forecast 2016-2027
7.4.6 Italian ENT Devices Market Forecast 2016-2027
7.5 The Japanese ENT Devices Market 2016-2027
7.6 The Chinese ENT Devices Market 2016-2027
7.7 The Indian ENT Devices Market 2016-2027
7.8 The Russian ENT Devices Market 2016-2027
7.8.1 Russia ENT Devices Market: Trends and Developments
7.9 The Brazilian ENT Devices Market 2016-2027
7.10 The South Korea ENT Devices Market 2016-2027
8. Leading Companies in the ENT Devices Market
8.1 William Demant Holding A/S
8.1.1 William Demant: ENT Product Portfolio
8.1.2 William Demant: Financial Overview
8.1.3 William Demant: Recent Developments
8.2. Cochlear Limited
8.2.1 Cochlear: ENT Product Portfolio
8.2.2 Cochlear: Financial Overview
8.2.3 Cochlear: Recent Developments
8.3 GN ReSound A/S
8.3.1 GN ReSound: ENT Product Portfolio
8.3.2 GN ReSound: Financial Overview
8.3.3 GN ReSound: Recent Developments
8.4 MED-EL
8.4.1 MED-EL: ENT Product Portfolio
8.4.2 MED-EL: Financial Overview

6. www.visiongain.com
Contents
8.4.3 MED-EL: Recent Developments
8.5 Sonova Holding AG
8.5.1 Sonova Holding: ENT Product Portfolio
8.5.2 Sonova Holding: Financial Overview
8.5.3 Sonova Holding: Recent Developments
9. Conclusions
9.1 The World ENT Devices Market in 2016 and 2017
9.2 Current Leading ENT Devices Segments
9.3 Leading ENT Companies
9.4 Leading Regional Markets
9.5 World ENT Devices Market Forecast 2017-2027
9.6 The Future of the ENT Devices Market?
10.Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B

7. www.visiongain.com
Contents
List of Figures
Figure 1.1: Hearing Loss: Market Opportunity
Figure 1.2: Global ENT Devices Market Segmentation, 2017
Figure 2.1: Prevalence of Hearing Loss
Figure 2.2: Estimates of Causes of preventable hearing loss
Figure 2.3: US Hearing Aid Market Penetration Estimations
Figure 2.4: Prevalence of Hearing Aid Use
Figure 3.1: Global ENT Devices Market Forecast 2016-2027 ($bn, AGR %)
Figure 3.2: ENT Devices Market by Product: Market Share (%), 2016
Figure 3.3: ENT Devices Market by Product: Market Share (%),2021
Figure 3.4: ENT Devices Market by Product: Market Share (%), 2027
Figure 4.1: Global ENT Endoscopes Market Forecast 2016-2027 ($bn, AGR %)
Figure 4.2: Global Rigid Endoscopes Market Forecast 2016-2027 ($bn, AGR %)
Figure 4.3: Global Flexible Endoscopes Market Forecast 2016-2027 ($bn, AGR %)
Figure 4.4: Global Flexible Endoscopes Market Forecast 2016-2027 ($bn, AGR %)
Figure 5.1: Global Surgical ENT Devices Market Forecast 2016-2027 ($bn, AGR %)
Figure 5.2: Global Powered Surgical Instrument Market Forecast 2016-2027 ($bn, AGR %)
Figure 5.3: Global Radiofrequency Devices Market Forecast 2016-2027 ($bn, AGR %)
Figure 5.4: Global Handheld Instrument Market Forecast 2016-2027 ($bn, AGR %)
Figure 5.5: Global Balloon Sinus Dilation Systems Market Forecast 2016-2027 ($bn, AGR %)
Figure 5.6: Global Nasal Splints & Stents Market Forecast 2016-2027 ($bn, AGR %)
Figure 5.7: Global Bronchial/Tracheal Stents Market Forecast 2016-2027 ($bn, AGR %)
Figure 5.8: Global Vent Tubes Market Forecast 2016-2027 ($bn, AGR %)
Figure 5.9: Global CO2 Lasers Market Forecast 2016-2027 ($bn, AGR %)
Figure 5.10: Global Image-guided Surgery Systems Market Forecast 2016-2027 ($bn, AGR
%)
Figure 6.1: Global Hearing Devices Market Forecast 2016-2027 ($bn, AGR %)
Figure 6.2: Global Hearing Aids Market Forecast 2016-2027 ($bn, AGR %)
Figure 6.3: Global Behind-the-Ear Aids Market Forecast 2016-2027 ($bn, AGR %)

8. www.visiongain.com
Contents
Figure 6.4: Global In-the-Ear Aids Market Forecast 2016-2027 ($bn, AGR %)
Figure 6.5: Global Receiver-In-the-Ear Market Forecast 2016-2027 ($bn, AGR %)
Figure 6.6: Global Canal Hearing Aids Market Forecast 2016-2027 ($bn, AGR %)
Figure 6.7: Global Cochlear Implants Market Forecast 2016-2027 ($bn, AGR %)
Figure 6.7: Global Hearing Implants Market Forecast 2016-2027 ($bn, AGR %)
Figure 6.8: Global Bone-Anchored Hearing Systems Market Forecast 2016-2027 ($bn, AGR
%)
Figure 6.9: Global Auditory Brainstem Implants Market Forecast 2016-2027 ($bn, AGR %)
Figure 6.10: Global Middle Ear Implants Market Forecast 2016-2027 ($bn, AGR %)
Figure 7.1: World ENT Devices Market by Region: Revenues ($bn), 2016
Figure 7.2: World ENT Devices Market by Region: Revenues ($bn), 2017
Figure 7.3: World ENT Devices Market by Region: Revenues ($bn), 2016-2027
Figure 7.4: World ENT Devices Market by Region: Market Shares (%), 2016
Figure 7.5: World ENT Devices Market by Region: Market Shares (%), 2021
Figure 7.6: World ENT Devices Market by Region: Market Shares (%), 2027
Figure 7.7: Development in Population with Hearing Loss in the US
Figure 7.8: Hearing Aid Penetration by Selected Countries
Figure 7.9: US ENT Devices Market Forecast: Revenues ($bn) and AGR (%). 2016-2027
Figure 7.10: EU5 ENT Devices Market Forecast: Revenues ($bn) and AGR (%). 2016-2027
Figure 7.11: EU5 ENT Devices Market: Market Shares (%) by National Markets, 2016
Figure 7.12: EU5 ENT Devices Market: Market Shares (%) by National Markets, 2021
Figure 7.13: EU5 ENT Devices Market: Market Shares (%) by National Markets, 2027
Figure 7.14: German ENT Devices Market Forecast: Revenues ($bn) and AGR (%), 2016-
2027
Figure 7.15 French ENT Devices Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
Figure 7.16 Prevalence of Hearing Loss in UK (millions)
Figure 7.17: UK ENT Devices Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
Figure 7.18: Spanish ENT Devices Market Forecast: Revenues ($bn) and AGR (%), 2016-
2027
Figure 7.19: Italian ENT Devices Market Forecast: Revenues ($bn) and AGR (%), 2016-2027

9. www.visiongain.com
Contents
Figure 7.20: The Route to the Hearing Aid
Figure 7.21: Hearing Loss Prevalence in Japan
Figure 7.22 Japanese ENT Devices Market Forecast: Revenues ($bn) and AGR (%), 2016-
2027
Figure 7.23: Chinese ENT Devices Market Forecast: Revenues ($bn) and AGR (%), 2016-
2027
Figure 7.24: Indian ENT Devices Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
Figure 7.25: Russia ENT Devices Market Forecast: Revenues ($bn) and AGR (%), 2016-
2027
Figure 7.26: Brazil ENT Devices Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
Figure 7.27: South Korea ENT Devices Market Forecast: Revenues ($bn) and AGR (%),
2016-2027
Figure 8.1: William Demant: ENT Devices Revenue ($bn) and AGR (%), 2016-2027
Figure 8.2: Cochlear Limited: ENT Devices Revenue ($bn) and AGR (%), 2016-2027
Figure 8.3: GN ReSound: ENT Devices Revenue ($bn) and AGR (%), 2016-2027
Figure 8.4: MED_EL: ENT Devices Revenue ($bn) and AGR (%), 2016-2027
Figure 8.5: Sonova Holding AG: ENT Devices Revenue ($bn) and AGR (%), 2016-2027

10. www.visiongain.com
Contents
List of Tables
Table 1.1: ENT Devices Market Forecast Segmented by National Market: Revenue ($bn),
AGR (%) and CAGR (%), 2016-2027 (redacted)
Table 2.1: Degree of Hearing Loss at Different Frequencies
Table 2.2: Common Signs of Hearing Loss
Table 2.3: Causes of Hearing Loss
Table 2.4: Common Symptoms of Sinusitis
Table 2.5: Demographic Development: Increasing Growth in the 65+ Population
Table 2.6: Hearing Healthcare Trends and Strategies
Table 3.1: Global Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) 2016-2027
Table 4.1: Global Diagnostic ENT Devices Market Forecast 2016-2027 ($bn, AGR %, CAGR
%)
Table 4.2: Global ENT Endoscopes Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 4.3: Global Rigid Endoscopes Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 4.4: Global Flexible Endoscopes Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 4.5: Global Flexible Endoscopes Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 5.1: Global Surgical ENT Devices Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 5.2: Global Powered Surgical Instrument Market Forecast 2016-2027 ($bn, AGR %,
CAGR %)
Table 5.3: Global Radiofrequency Devices Market Forecast 2016-2027 ($bn, AGR %, CAGR
%)
Table 5.4: Global Handheld Instrument Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 5.5: Global Balloon Sinus Dilation Systems Market Forecast 2016-2027 ($bn, AGR %,
CAGR %)
Table 5.6: Global Nasal Splints & Stents Market Forecast 2016-2027 ($bn, AGR %, CAGR
%)
Table 5.7: Global Bronchial/Tracheal Stents Market Forecast 2016-2027 ($bn, AGR %,
CAGR %)
Table 5.8: Global Vent Tubes Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 5.9: Global CO2 Lasers Market Forecast 2016-2027 ($bn, AGR %, CAGR %)

11. www.visiongain.com
Contents
Table 5.10: Global Image-guided Surgery Systems Market Forecast 2016-2027 ($bn, AGR
%, CAGR %)
Table 6.1: Global Hearing Devices Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 6.2: Strong Growth Opportunities in the Implant Market
Table 6.3: Global Hearing Aids Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 6.4: Global Behind-the-Ear Aids Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 6.5: Global In-the-Ear Aids Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 6.6: Global Receiver-In-the-Ear Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 6.7: Global Canal Hearing Aids Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 6.8: Global Cochlear Implants Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 6.8: Global Hearing Implants Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 6.9: Global Bone-Anchored Hearing Systems Market Forecast 2016-2027 ($bn, AGR
%, CAGR %)
Table 6.10: Global Auditory Brainstem Implants Market Forecast 2016-2027 ($bn, AGR %,
CAGR %)
Table 6.11: Global Middle Ear Implants Market Forecast 2016-2027 ($bn, AGR %, CAGR %)
Table 7.1: World ENT Devices Market by Region:Revenues ($bn) and Market Share (%),
2016 and 2017
Table 7.2: World ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR (%),
2016-2027
Table 7.2: World ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR (%),
2016-2027 (continued)
Table 7.3: World ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR (%),
2016-2027
Table 7.4: Annual Economic Costs to European Countries Due to Hearing Loss, 2013
Table 7.5: EU5 ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR (%),
2016-2027
Table 7.6: German ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR
(%), 2016-2027
Table 7.7: French ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR
(%), 2016-2027

12. www.visiongain.com
Contents
Table 7.8: UK ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR (%),
2016-2027
Table 7.9: Spanish ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR
(%), 2016-2027
Table 7.10: Italian ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR
(%), 2016-2027
Table 7.11: Japanese ENT Devices Market by Region: Revenues ($bn), AGR (%), and
CAGR (%), 2016-2027
Table 7.12: Chinese ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR
(%), 2016-2027
Table 7.13: Indian ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR
(%), 2016-2027
Table 7.14: Russia ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR
(%), 2016-2027
Table 7.15: Brazil ENT Devices Market by Region: Revenues ($bn), AGR (%), and CAGR
(%), 2016-2027
Table 7.16: South Korea ENT Devices Market by Region: Revenues ($bn), AGR (%), and
CAGR (%), 2016-2027
Table 8.1: William Demant Holding A/S Overview
Table 8.2: William Demant: ENT Devices Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 8.3: Cochlear Limited, Overview
Table 8.4: Cochlear Limited: ENT Devices Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 8.5: GN ReSound A/S, Overview
Table 8.6: GN ReSound: ENT Devices Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 8.7: MED-EL
Table 8.8: MED-EL: ENT Devices Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 8.9: Sonova Holding AG, Overview
Table 8.10: Sonova Holding AG: ENT Devices Revenue ($bn), AGR (%), CAGR (%), 2016-
2027

13. www.visiongain.com
Contents
List of Companies
Acoustic Implants Limited
Advanced Bionics AG
Advanced Bionics LLC
Amplivox
Anovum
Audigy Group
Audika Groupe
AudioNova Group
AudioNova International B.V.
Auris Medical Holding AG
Auris Medical's
Beltone
Bernafon
Cochlear AG
Cochlear Americas
Cochlear Austria GmbH
Cochlear Bone Anchored Solutions AB
Cochlear Limited
Connect Hearing Inc.
Costco
Duthey
FrontRow
GN Hearing A/S
GN ReSound (NZ) Ltd.
GN ReSound A/S
Hansaton Akustik GmbH
GN ReSound China Ltd.

14. www.visiongain.com
Contents
GN Resound Japan K.K.
GN ReSound Pty. Ltd.
GN ReSound Shanghai Ltd.
GN Store Nord AS
Grason-Stadler
Indomed AG
Interacoustics
Interton
IntriCon
Italian Amplifon Group
MAICO Diagnostics GmbH
MED-EL Corporation
MED-EL Deutschland GmbH
MED-EL GMBH Niederlassung Wien
MED-EL Implant Systems Australasia Pty Ltd
MED-EL India Private Ltd.
MED-EL USA
MedRx
Micromedical
Olympus
Oticon Inc.
Otometrics
Phonak LLC
Phonic Ear
REACH
ReSound
Sennheiser Communications A/S
Siemens
Sivantos

15. www.visiongain.com
Contents
Smart Hearing Alliance
Sonic
Sonova AG
Sonova Australia Pty Ltd
Sonova Canada Inc.
Sonova do Brasil Produtos Audiológicos Ltda.
Sonova Group
Sonova Holding AG
Starkey Hearing Technologies
Widex
William Demant Holding A/S

16. www.visiongain.com
Contents
List of Organizations
ADA
American College of Allergy, Asthma & Immunology
American Speech-Language-Hearing Association (ASHA)
Better Hearing Institute
Central Drug Standard Control Organisation (CDSCO)
Centre for Devices and Radiological Health (CDRH)
Databank on Medical Devices (EUDAMED)
European Hearing Instrument Manufacturer Association (EHIMA)
European Investment Bank (EIB)
EuroTrak Italy
Food and Drug Administration (FDA)
France’s Autorité de la concurrence
Global Harmonisation Task Force (GHTF)
Hearing Loss Association of America
Institutional Review Board (IRB)
International Medical Device Regulators Forum (IMDRF)
Madrid government
Ministry of Health, Labor, and Welfare (MHLW)
National Cancer Institute
National Deaf Children’s Society
National Health Service
National Institute of Clinical Excellence (NICE)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institutes of Health
Pharmaceuticals and Medical Device Agency (PDMA)
Russian Ministry of Industry
Sistema Unico de Saude (SUS

17. www.visiongain.com
Contents
United Nations
Veteran Affairs (VA)
World Bank
World Economic Forum
World Health Organization (WHO)

18. Page 62visiongain.com
The Global ENT Devices Market Forecast 2017-2027
Revenue Prospects by Type (Diagnostic, Surgical, Hearing Devices), by Product (including
Endoscopes, Surgical Instruments, Stents, CO2 Lasers, Vent Tubes, Hearing Aids, Hearing
Implants and more) and Geography
5.8 CO2 Lasers Market Forecast 2016-2027
The use of lasers is a very common practice in ENT surgeries today as laser surgery is minimally
invasive, highly precise and suitable for treatment of wide range of ENT disorders. The most
commonly used source is CO2 laser as it provides high degree of precision cutting and outstanding
coagulation effect. Apart from CO2 lasers, diode lasers and thulium lasers are also used for ENT
surgeries. Use of lasers provides easier, safer, faster and more effective treatment with minimum
or no damage to the surrounding tissues. Hence, lasers are used in several ENT surgeries
including transoral laryngeal microsurgery, middle ear surgery, oral surgery, nasal, endonasal &
endoscopic sinus surgery, surgery of tracheobronchial tree and head & neck surgeries.
Today, the use of CO2 lasers in ENT surgery is the most common practice followed in the ENT
industry. These lasers generate continuous wave of coherent light at a wave length of 10600 nm.
These waves are absorbed by soft tissues. CO2 laser beam can seal blood vessels up to 0.5 mm
in diameter. Thus, these lasers are increasingly becoming a first line of treatment for early stage
airway cancers. The ENT field has advanced significantly primarily due to the introduction of CO2
lasers. The market for CO2 lasers is attributed to its wide applications in different aspects of
surgery in the ear, nose, larynx, and neck. This also helps in performing quality ENT surgery.
Applications of the CO2 laser in ENT Surgery:
• Surgery for Hoarseness of the Voice: Polyps, Vocal Cord Palsy, and Vocal Cord Nodules
• Surgery for Deafness & Ear Discharge: Otoneurosurgery and Stapes Surgery
• Surgery of the Nose & Sinuses: Laser Assisted Endoscopic Sinus Surgery
• Surgery for Snoring: Laser Assisted Uvulopalatoplasty
Table 5.9: Global CO2 Lasers Market Forecast 2016-2027 ($bn, AGR %,
CAGR %)
- 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Sales ($bn) 0.20 0.22 0.25 0.28 0.31 0.35 0.39 0.43 0.47 0.51 0.56 0.61
AGR (%) - 13.4 12.8 12.3 11.8 11.2 10.7 10.3 9.8 9.4 8.9 8.5
CAGR 2016-21 (%) 12.3 CAGR (%) 2022-27 9.4
CAGR 2016-27 (%) 10.8
Source: visiongain 2017

19. Page 110visiongain.com
The Global ENT Devices Market Forecast 2017-2027
Revenue Prospects by Type (Diagnostic, Surgical, Hearing Devices), by Product (including
Endoscopes, Surgical Instruments, Stents, CO2 Lasers, Vent Tubes, Hearing Aids, Hearing
Implants and more) and Geography
7.8 The Russian ENT Devices Market 2016-2027
Hearing problems are widespread among Russia children. An estimated 60,000 children suffer
from hearing loss in the country. On an average, 1 child in 1,000 is born deaf, some due to gene
defects and others because of some other problems.
The Russian healthcare market is one of the fastest growing in the world and its healthcare
expenditure per capita has increased markedly in recent years. The government’s Project Health
programme, initiated in 2008, is attempting to ensure that 50% of all Russian’s pharmaceuticals
are domestically produced by 2020. The per capita drug spending in Russia is currently around five
times less than western economies, suggesting potential for further expansion in coming years.
Other drivers in the Russian healthcare system include the Russian healthcare programme’s aims
to stop decline in population and increase average life expectancy to 75 years by 2020. This will
primarily be achieved through increased healthcare expenditure, aiming to rise from $66bn in 2009
to $284bn in 2020.
The Russian ENT devices market was estimated at $0.33bn in 2016. Russia had the eight largest
GDP in the world (according to the World Bank in December 2013) and the highest per capita
spending on healthcare of all the BRIC nations; with the middle class accounting for a high
proportion of its approximately 146 million people. Despite Russia being a rapidly developing
economy, it accounted for only of the global ENT devices market in 2016. However, with the
recent recession Russia has experienced, with the steepest decline in GDP since 2009 as a result
of reduced oil prices and international sanctions, Russian consumers and healthcare purchasing
power will be heavily impacted with an increase in the cost of goods and reduction in government
spending. Analysts forecast that GDP growth will return to previous levels by 2017, and this
economic downturn is transient and will not have far reaching consequences.
Table 7.14: Russia ENT Devices Market by Region: Revenues ($bn), AGR
(%), and CAGR (%), 2016-2027
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Russia 0.33 0.36 0.38 0.41 0.44 0.48 0.51 0.54 0.58 0.62 0.66 0.70
AGR (%) - 8.2 8.0 7.7 7.5 7.2 7.0 6.8 6.6 6.5 6.3 6.2
CAGR (%) 2016-
2021
7.7 CAGR (%) 2022-2027 6.5
CAGR (%) 2016-
2027
7.1
Source: visiongain 2017

20. Page 123visiongain.com
The Global ENT Devices Market Forecast 2017-2027
Revenue Prospects by Type (Diagnostic, Surgical, Hearing Devices), by Product (including
Endoscopes, Surgical Instruments, Stents, CO2 Lasers, Vent Tubes, Hearing Aids, Hearing
Implants and more) and Geography
8.3 GN ReSound A/S
Table 8.5: GN ReSound A/S, Overview
Company GN ReSound
Notable Subsidiaries GN ReSound Pty. Ltd., GN ReSound Shanghai Ltd., GN
ReSound China Ltd., GN Resound Japan K.K., and GN
ReSound (NZ) Ltd.
Business Areas Hearing Solutions
Headquarters Ballerup, Denmark
Established 1943
Leading Products ReSound LiNX, ReSound Enya, ReSound Magna, ReSound
ENZO, ReSound LiNX, ReSound Vea, ReSound Up Smart,
ReSound Verso, ReSound Alera, ReSound ENZO, and
ReSound Lex
FY 2016 ENT Revenue ($bn) 0.69
GN ReSound is one of the leading providers of innovative hearing solutions globally. The company
develops and manufactures hearing aids, accessories, and apps for the people suffering from
severe to profound hearing loss. The company was founded in 1943 and is headquartered in
Denmark. It has over 4,100 employees, and has a strong geographical presence with offices in
more than 25 countries and distributors in over 80 countries. GN ReSound operates as a
subsidiary of GN Store Nord AS.
In May 2016, GN Store Nord AS changed its legal company names in order to support a renewed
brand platform. Hence, GN ReSound A/S has changed its name to GN Hearing A/S. However, the
company’s flagship brand remains as ReSound and it will continue operating other brands
(including Beltone, Interton and Otometrics) under the umbrella, GN Hearing.